Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Sacubitril or its salts I JAN / 16
Safinamide or its salts I FEB / 19
Salbutamol or its salts I DEC / 13
Salicylic acid

When sold in topical formulations containing salicylic acid at concentrations greater than 20% and/or with a pH less than 3.0, except when sold to be applied to warts, corns or calluses.

I DEC / 14
Salicylic acid and its salts when sold to be applied to warts, corns or calluses in topical preparations in concentrations greater than 40% II DEC / 14
Salmeterol or its salts I DEC / 13
Salsalate or its salts or derivatives I DEC / 13
Sapropterin or its salts I DEC / 13
Saquinavir or its salts or derivatives I DEC / 13
Saralasin or its salts I DEC / 13
Sargramostim I DEC / 13
Sarilumab I MAR / 17
Sarolaner

For veterinary use.

I AUG / 16
Satralizumab I SEP / 20
Saxagliptin or its salts I DEC / 13
Sebelipase alfa I MAR / 18
SecobarbitalC1 I JUN / 02
Secukinumab I MAY / 15
Selegiline or its salts I DEC / 13
Selenium in injectable form for parenteral nutrition I JAN / 03
Selexipag or its derivatives I AUG / 16
Semaglutide I MAR / 18
Sermorelin or its salts I DEC / 13
Sertraline or its salts I DEC / 13
Sevelamer or its salts I DEC / 13
Sevoflurane I DEC / 13
Sex hormones (natural or synthetic)

For human use - including but not limited to conjugated estrogens, desogestrel, dienogest, estradiol benzoate, estradiol(hemihydrate), estrone, ethinyl estradiol, ethynodiol diacetate, etonogestrel, levonorgestrel, medroxyprogesterone acetate, norelgestromin, norethindrone acetate, norgestimate, progesterone except the following: androisoxazole, androstanolone, androstenediol or its derivatives, bolandiol or its derivatives, bolasterone, bolazine, boldenone or its derivatives, bolenol, calusterone, clostebol or its derivatives, drostanolone or its derivatives, enestebol, epitiostanol, ethylestrenol, fluoxymesterone, formebolone, furazabol, 4-Hydroxy-19-nortestosterone or its derivatives, levonorgestrel when sold as a single ingredient in an oral dosage form containing no more than 1.5 milligrams, mebolazine,mesabolone, mesterolone, metandienone, metenolone or its derivatives, methandriol, methyltestosterone or its derivatives, metribolone, mibolerone, nandrolone or its derivatives, norboletone, norclostebol or its derivatives, norethandrolone, oxabolone or its derivatives, oxandrolone, oxymesterone, oxymetholone, prasterone, quinbolone, stanozolol, stenbolone or its derivatives, testosterone or its derivatives, tibolone, tiomesterone, trenbolone or its derivatives, zeranol.

I AUG / 15
Sibutramine or its salts I DEC / 13
Sildenafil or its salts I DEC / 13
Silodosin or its salts or derivatives I DEC / 13
Siltuximab I DEC / 14
Silver nitrate II SEP / 98
Simeprevir or its salts I DEC / 13
Simvastatin I DEC / 13
Sincalide II SEP / 98
Siponimod or its salts I JUL / 20
Sirolimus or its derivatives

Including but not limited to everolimus, temsirolimus.

I DEC / 13
Sitagliptin or its salts I DEC / 13
Sitaxentan or its salts I DEC / 13
Sodium Zirconium cyclosilicate I OCT / 19
Sodium acetate for parenteral use II SEP / 98
Sodium acetate in injectable form for parenteral nutrition I JAN / 03
Sodium biphosphate

for parenteral use

II SEP / 98
Sodium bromide I DEC / 13
Sodium chloride single ingredient solutions for parenteral or ophthalmic use in concentrations of more than 0.9% [NOTE: Does not apply to contact lens solutions intended to be rinsed off prior to insertion into eye] II OCT / 98
Sodium chloride in injectable form for parenteral nutrition I JAN / 03
Sodium citrate for parenteral use II SEP / 98
Sodium cromoglicate (cromoglycate) in solutions in concentrations of 2% or less for ophthalmic or nasal use III SEP / 98
Sodium fluoride (see Fluoride)

For human use - in solid oral dosage forms containing more than 1 mg of fluoride ion.

I DEC / 13
Sodium iodide for sclerosing II SEP / 98
Sodium iodine in injectable form for parenteral nutrition I JAN / 03
Sodium nitrite

When indicated for administration by injection and sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning.

I JUN / 15
Sodium nitroprusside or its salts I DEC / 13
Sodium phosphate for parenteral use II SEP / 98
Sodium phosphate in injectable form for parenteral nutrition I JAN / 03
Sodium picosulphate

for oral purgatives, 10 mg per pack (when found in preparations with magnesium oxide 3.5 g and citric acid 12 g)

II JAN / 10
Sodium polystyrene sulfonate I DEC / 13
Sodium tetradecylsulfate II SEP / 98
Sofosbuvir or its salts I FEB / 14
Solifenacin or its salts I DEC / 13
Somatostatin I DEC / 13
Somatrem I DEC / 13
Somatropin I DEC / 13
Sonidegib or its salts I SEP / 20
Sorafenib or its salts I DEC / 13
Sotalol or its salts I DEC / 13
Spectinomycin or its salts or derivatives I DEC / 18
Spinosyn A and D isoforms I DEC / 13
Spiramycin or its salts or derivatives

For human use.

I DEC / 13
Spironolactone I DEC / 13
StanozololC3 I JUN / 02
Stavudine I DEC / 13
StenboloneC3 I JUN / 02
Stiripentol I DEC / 13
Stramonium, its preparations, extracts and compounds II SEP / 98
Streptokinase as a debriding agent II SEP / 98
Streptokinase/streptodornase I SEP / 98
Streptomycin or its salts or derivatives

For human use

I DEC / 18
Streptomycin or its salts or derivatives

For veterinary use, including but not limited to dihydrostreptomycin

I DEC / 18
Streptozocin I DEC / 13
Strontium and its salts for parenteral use II SEP / 98
Strontium bromide I DEC / 13
Succinimide or its salts or derivatives

Including but not limited to methsuximide, except those compounds used for decontaminating water.

I DEC / 13
Succinylcholine and its salts I SEP / 98
Sucralfate I SEP / 98
Sucroferric oxyhydroxide I MAY / 18
SufentanilN I JUN / 02
Sugammadex or its salts I AUG / 16
Sulconazole or its salts I DEC / 13
Sulfinpyrazone or its salts I DEC / 13
Sulindac or its salts I DEC / 13
Sulphonamides or their salts or derivatives

Including but not limited to Brinzolamide, succinylsulfathiazole, sulfacetamide, sulfadiazine, sulfadimethoxine, sulfadoxine, sulfaguanidine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfanilamide, sulfapyridine, sulfaquinoxaline, sulfasalazine, sulfathiazole, sulfisoxazole, sulphanilamide

I DEC / 18
Sulphones or their derivatives

Including but not limited to dapsone. 

I DEC / 13
Sumatriptan or its salts I DEC / 13
Sunitinib or its salts I DEC / 13
Suprofen or its salts I DEC / 13
Sutilains II SEP / 98
Suvorexant I DEC / 18
Suxamethonium chloride I DEC / 13
Synthetic cannabinoid receptor type-1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomersN

as listed in the schedules to the Controlled Drugs and Substances Act and the Narcotic Control Regulations

I JUL / 15

100 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act